Missed your GLP‑1 dose? The label rule, in one sentence
The FDA label rule for a missed Wegovy, Ozempic, Zepbound, Mounjaro or Rybelsus dose: take it or skip it, decided by your drug and how late you are.
How this tool works
The decision rules are transcribed — not paraphrased — from the dosage-and-administration section of each drug’s current FDA label: Wegovy PI §2.2, Ozempic PI §2.1, Zepbound PI §2.2, Mounjaro PI §2.2 and Rybelsus PI §2.1. Your timing input just selects which branch of the label applies.
Wegovy’s rule reads differently from Ozempic’s but lands in nearly the same place: “take it if the next scheduled dose is more than 48 hours away” means a weekly injector has about 5 days to catch up. Zepbound and Mounjaro give 4 days (96 hours). Daily Rybelsus never catches up — the missed day is simply skipped.
Limits: labels are revised; we re-verify on each revision and date-stamp every rule. Two or more consecutive missed doses is a prescriber conversation — restarting at a lower dose may be safer than resuming, and that judgment is theirs, not a calculator’s.
Missed-dose questions, answered directly
This tool restates label instructions; it is not medical advice and cannot see your history. Persistent vomiting, severe abdominal pain or signs of dehydration after a dosing error are prescriber-now problems — when in doubt, call. Labels are re-verified on each revision.
- FDA prescribing informationThe labels for every product a tool names, on the label holder’s own site
- Manufacturer cash programsNovoCare, LillyDirect and TrumpRx published self-pay prices
- CMS NADACNational Average Drug Acquisition Cost, weekly file
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.
